Most recently sold 34,000 shares in Apr 2023. Currently holds stock worth $8.34M. Has donated $4.60M in stock to charitable causes. Led Veracyte as CEO for 8 years.
Compensation History
Annual executive compensation data for Bonnie H. Anderson, including salary, bonuses, and stock awards.
Year
2021
Total Compensation
$0.00
Salary
$0.00
Bonus
$0.00
Other
$0.00
Salary
$0.00Board Justification
The compensation philosophy aligns with company performance and retention strategies, focusing on competitive market data and executive contributions.
Bonus
$0.00Board Justification
No bonus was reported for 2021.
Other Compensation
$0.00Board Justification
No other compensation was reported for 2021.
Restricted Stock
Board Justification
No stock was reported as vested in 2021.
Performance Metrics
Performance metrics for compensation determination were not specified in the provided section.
Bonnie H. Anderson
Founder and Ex-CEO of Veracyte
Education
B.S. in Biology from the University of California, San Diego and an M.B.A. from the Wharton School of the University of Pennsylvania.
Field of Expertise
Healthcare & Life Sciences - Biotechnology
Sector of Economy
Healthcare
Born
January 1, 1963 - 62 years ago
CEO of Veracyte for
8 years 3 months (Apr 2013 - Jul 2021)
Previous Experience
President and Chief Executive Officer of Veracyte, Inc. since its founding in 2013, previously held various executive roles in the biotechnology and life sciences industries.
Other Veracyte CEOs
Holdings
Track Bonnie H. Anderson's stock holdings and portfolio value over time.
Total Stock Sold
$27.67M
$26.94M
959,906 VCYT shares
$730.99K
19,000 CSTL shares
What if they kept their stock?
If Bonnie H. Anderson didn't sell their stock, today they would have:
Extra VCYT959,906 shares worth $42.82M and CSTL19,000 shares worth $734.16K.
This is 57.41% and $15.88M more than what they got when they sold the stock.
Charitable Transactions
103,112 shares
VCYT
Recent Charitable Transactions
45,812 shares
VCYT
Nov 10, 2020
Charity
50,000 shares
VCYT
Aug 6, 2020
Charity
7,300 shares
VCYT
Mar 11, 2019
Charity
Insider Trading
Bonnie H. Anderson's recent stock transactions, purchases, and sales filed with the SEC.
$749.36K
VCYT at $22.04/share
Apr 14, 2023
Sale
$773.89K
VCYT at $22.76/share
Mar 15, 2023
Sale
$900.06K
VCYT at $26.47/share
Jan 17, 2023
Sale
$1.59M
VCYT at $25.13/share
Jan 11, 2023
Sale
$2.26M
VCYT at $28.21/share
Dec 1, 2022
Sale
$3.36M
VCYT at $27.59/share
Aug 5, 2022
Sale
17,667 shares
VCYT
Mar 3, 2022
Received
$130.48K
VCYT at $50.18/share
Sep 17, 2021
Sale
$95.05K
VCYT at $50.03/share
Sep 10, 2021
Sale
20,000 shares
VCYT
Feb 26, 2021
Received
Rivals
Compare Bonnie H. Anderson with competitor CEOs and industry peers.
John Evans
CEO of Beam Therapeutics
2023 Compensation
Stock
$0.00
Salary
$685.00K
Bonus
$431.55K
Other
$17.68K
Total Holdings
$2.47M
Kimberly J. Popovits
CEO of 10x Genomics, Inc.
2023 Compensation
Stock
$0.00
Salary
$0.00
Bonus
$0.00
Other
$0.00
Total Holdings
$286.13K
Chad Robins
Founder and CEO of Adaptive Biotechnologies
2023 Compensation
Stock
$716.86K
Salary
$663.00K
Bonus
$318.24K
Other
$22.32K
Total Holdings
$118.69M
AmirAli Talasaz
Founder and CEO of Guardant Health
2023 Compensation
Stock
$0.00
Salary
$1.00
Bonus
$0.00
Other
$26.41K
Total Holdings
$11.66M